
EverQuote, Inc. (NASDAQ:EVER – Free Report) – Stock analysts at Zacks Research lifted their Q1 2027 earnings per share estimates for shares of EverQuote in a research note issued on Tuesday, January 6th. Zacks Research analyst Team now forecasts that the company will post earnings of $0.54 per share for the quarter, up from their previous estimate of $0.52. Zacks Research has a “Strong-Buy” rating on the stock. The consensus estimate for EverQuote’s current full-year earnings is $0.72 per share.
EverQuote (NASDAQ:EVER – Get Free Report) last issued its quarterly earnings data on Monday, November 3rd. The company reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.13. The company had revenue of $173.94 million during the quarter, compared to the consensus estimate of $166.09 million. EverQuote had a return on equity of 38.19% and a net margin of 8.36%.The firm’s revenue was up 20.3% compared to the same quarter last year. During the same period last year, the company earned $0.31 earnings per share.
Get Our Latest Stock Report on EVER
EverQuote Price Performance
Shares of EVER stock opened at $25.21 on Thursday. EverQuote has a one year low of $17.20 and a one year high of $30.03. The business’s 50 day simple moving average is $25.94 and its 200 day simple moving average is $24.26. The stock has a market capitalization of $906.55 million, a PE ratio of 17.63 and a beta of 0.46.
Insider Activity at EverQuote
In other EverQuote news, CEO Jayme Mendal sold 14,360 shares of the firm’s stock in a transaction on Monday, December 22nd. The shares were sold at an average price of $27.25, for a total value of $391,310.00. Following the completion of the sale, the chief executive officer directly owned 438,052 shares in the company, valued at approximately $11,936,917. This trade represents a 3.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director John L. Shields sold 2,000 shares of the company’s stock in a transaction dated Monday, October 13th. The shares were sold at an average price of $20.78, for a total transaction of $41,560.00. Following the transaction, the director owned 27,219 shares in the company, valued at $565,610.82. This represents a 6.84% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 53,798 shares of company stock valued at $1,271,877 in the last ninety days. Insiders own 25.52% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Comerica Bank grew its stake in EverQuote by 235.4% in the third quarter. Comerica Bank now owns 1,100 shares of the company’s stock valued at $25,000 after acquiring an additional 772 shares during the period. Versant Capital Management Inc lifted its holdings in shares of EverQuote by 108.9% in the 3rd quarter. Versant Capital Management Inc now owns 1,153 shares of the company’s stock worth $26,000 after purchasing an additional 601 shares in the last quarter. NewEdge Advisors LLC bought a new position in shares of EverQuote in the 3rd quarter worth $52,000. Jones Financial Companies Lllp grew its position in EverQuote by 595.8% in the 3rd quarter. Jones Financial Companies Lllp now owns 2,623 shares of the company’s stock valued at $62,000 after purchasing an additional 2,246 shares during the period. Finally, Ameritas Investment Partners Inc. increased its stake in EverQuote by 25.8% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,796 shares of the company’s stock valued at $68,000 after purchasing an additional 573 shares in the last quarter. Institutional investors own 91.54% of the company’s stock.
Trending Headlines about EverQuote
Here are the key news stories impacting EverQuote this week:
- Positive Sentiment: Zacks upgraded EverQuote to a Zacks Rank #1 (Strong Buy), citing stronger earnings outlook and higher estimates — a direct catalyst for investor optimism. Read More.
- Positive Sentiment: Zacks Research has raised Q1–Q3 and FY2026/2027 EPS forecasts (multiple upward revisions), lifting FY2027 to ~$2.02 and FY2026 to ~$1.76 — these higher earnings trajectories support valuation expansion. Read More.
- Positive Sentiment: Technicals show a hammer candlestick pattern and potential support, suggesting a near-term turnaround that could attract momentum buyers alongside the analyst upgrades. Read More.
- Neutral Sentiment: EverQuote management will present at the 28th Annual Needham Growth Conference — provides a forum for refreshed guidance and one‑on‑one investor meetings but is not itself a guaranteed near‑term catalyst. Read More.
- Negative Sentiment: Insider selling: CFO Joseph Sanborn sold 1,063 shares and CAO Jon Ayotte sold 675 shares in early January — small percentage reductions in holdings but items investors watch for timing/context. Read More. Read More.
EverQuote Company Profile
EverQuote, Inc operates an online insurance marketplace that connects consumers with insurance providers across the United States. Founded in 2011 and headquartered in Cambridge, Massachusetts, the company leverages proprietary technology to match individuals seeking coverage with insurers offering competitive rates. Since its initial public offering in 2020, EverQuote has focused on expanding its digital platform and enhancing the efficiency of its lead-generation processes.
The company’s core business centers on a quote-comparison engine for personal auto, home, and health insurance products.
See Also
- Five stocks we like better than EverQuote
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Do not delete, read immediately
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for EverQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EverQuote and related companies with MarketBeat.com's FREE daily email newsletter.
